Full Text Journal Articles by
Author Anja Reuter

Advertisement

Find full text journal articles








Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic.

Erika Mohr-Holland, Bianca Douglas-Jones, Ivy Apolisi, Noluvo Ngambu, Shaheed Mathee, Rabia Cariem, Vanessa Mudaly, Colin Pfaff, Petros Isaakidis, Jennifer Furin, Anja Reuter,

Lancet Child Adolesc Health (The Lancet. Child & adolescent health)
[2021, 5(3):159-161]

Cited: 0 times

View full text PDF listing >>



The problem with vitamin D supplementation for tuberculosis.

Anja Reuter, Jennifer Furin,

Lancet HIV (The lancet. HIV)
[2020, 7(7):e450-e451]

Cited: 0 times

View full text PDF listing >>



Advertisement

Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?

Norbert Ndjeka, Francesca Conradie, Graeme Meintjes, Anja Reuter, Jennifer Hughes, Xavier Padanilam, Nazir Ismail, Yulene Kock, Iqbal Master, Rodolfo Romero, Julian Te Riele, Martin Enwerem, Hannetjie Ferreira, Gary Maartens,

Eur Respir J (The European respiratory journal)
[2020, 56(1):]

Cited: 1 time

View full text PDF listing >>



Correspondence regarding "Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa".

Erika Mohr-Holland, Anja Reuter, Jennifer Hughes, Johnny Daniels, Busisiwe Beko, Goodman Makhanda, Virginia De Avezedo, Yulene Kock, Helen Cox, Jennifer Furin, Laura Trivino Duran, Petros Isaakidis, Gabriella Ferlazzo,

Eur Respir J (The European respiratory journal)
[2020, 56(1):]

Cited: 0 times

View full text PDF listing >>



Treating drug-resistant tuberculosis infection: no more excuses.

Anja Reuter, Jennifer Furin,

Clin Infect Dis (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Preventing tuberculosis in children: A global health emergency.

Anja Reuter, James A Seddon, Ben J Marais, Jennifer Furin,

It is estimated that 20 million children are exposed to tuberculosis (TB) each year, making TB a global paediatric health emergency. TB preventative efforts have long been overlooked. With the view of achieving "TB elimination" in "our lifetime", this paper explores challenges and potential solutions in the TB prevention cascade, ... Read more >>

Paediatr Respir Rev (Paediatric respiratory reviews)
[2020, 36:44-51]

Cited: 0 times

View full text PDF listing >>



Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa.

Erika Mohr-Holland, Anja Reuter, Jennifer Furin, Anthony Garcia-Prats, Virginia De Azevedo, Vanessa Mudaly, Yulene Kock, Laura Trivino-Duran, Petros Isaakidis, Jennifer Hughes,

Background:Limited data exist on the use of bedaquiline and delamanid in adolescents with rifampicin-resistant tuberculosis (RR-TB). We describe RR-TB treatment of adolescents (10-19 years) with injectable-free regimens containing these drugs in Khayelitsha, South Africa. Methods:This retrospective study included adolescents initiating injectable-free RR-TB treatment regimens containing bedaquiline and/or delamanid from February ... Read more >>

EClinicalMedicine (EClinicalMedicine)
[2020, 20:100290]

Cited: 0 times

View full text PDF listing >>



Challenges and controversies in childhood tuberculosis.

Anja Reuter, Jennifer Hughes, Jennifer Furin,

Children bear a substantial burden of suffering when it comes to tuberculosis. Ironically, they are often left out of the scientific and public health advances that have led to important improvements in tuberculosis diagnosis, treatment, and prevention over the past decade. This Series paper describes some of the challenges and ... Read more >>

Lancet (Lancet (London, England))
[2019, 394(10202):967-978]

Cited: 1 time

View full text PDF listing >>



Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.

Margaretha de Vos, Serej D Ley, Kristin B Wiggins, Brigitta Derendinger, Anzaan Dippenaar, Melanie Grobbelaar, Anja Reuter, Tania Dolby, Scott Burns, Marco Schito, David M Engelthaler, John Metcalfe, Grant Theron, Annelies van Rie, James Posey, Rob Warren, Helen Cox,

N Engl J Med (The New England journal of medicine)
[2019, 380(22):2178-2180]

Cited: 6 times

View full text PDF listing >>



The STREAM trial: missed opportunities and lessons for future clinical trials.

Marian Loveday, Anja Reuter, Jennifer Furin, James A Seddon, Helen Cox,

Lancet Infect Dis (The Lancet. Infectious diseases)
[2019, 19(4):351-353]

Cited: 1 time

View full text PDF listing >>



Demanding an end to tuberculosis: treatment of tuberculosis infection among persons living with and without HIV.

Justine Fargher, Anja Reuter, Jennifer Furin,

<h4>Purpose of review</h4>More than two billion people are infected with Mycobacterium tuberculosis and few of them are ever offered therapy in spite of such treatment being associated with reduced rates of morbidity and mortality. This article reviews the current recommendations on the diagnosis and treatment of TB infection (or what ... Read more >>

Curr Opin HIV AIDS (Current opinion in HIV and AIDS)
[2019, 14(1):21-27]

Cited: 0 times

View full text PDF listing >>



Reducing harm in the treatment of multidrug-resistant tuberculosis.

Anja Reuter, Jennifer Furin,

Lancet (Lancet (London, England))
[2018, 392(10150):797-798]

Cited: 1 time

View full text PDF listing >>



Bedaquiline use in South Africa reveals a lifesaving policy in action.

Anja Reuter, Jennifer Furin,

Lancet Respir Med (The Lancet. Respiratory medicine)
[2018, 6(9):653-655]

Cited: 0 times

View full text PDF listing >>



Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa.

Erika Mohr, Jennifer Hughes, Anja Reuter, Laura Trivino Duran, Gabriella Ferlazzo, Johnny Daniels, Virginia De Azevedo, Yulene Kock, Sarah Jane Steele, Amir Shroufi, Serge Ade, Natavan Alikhanova, Guido Benedetti, Jeffrey Edwards, Helen Cox, Jennifer Furin, Petros Isaakidis,

Experience with delamanid (Dlm) is limited, particularly among HIV-positive individuals. We describe early efficacy and safety data from a programmatic setting in South Africa.This was a retrospective cohort study of patients receiving Dlm-containing treatment regimens between November 2015 and August 2017. We report 12-month interim outcomes, sputum culture conversion (SCC) ... Read more >>

Eur Respir J (The European respiratory journal)
[2018, 51(6):]

Cited: 5 times

View full text PDF listing >>



Prevention of hearing loss in patients with multidrug-resistant tuberculosis.

Helen Cox, Anja Reuter, Jennifer Furin, James Seddon,

Lancet (Lancet (London, England))
[2017, 390(10098):934]

Cited: 1 time

View full text PDF listing >>



Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes.

Viviane D Lima, Anja Reuter, P Richard Harrigan, Lillian Lourenço, William Chau, Mark Hull, Lauren Mackenzie, Silvia Guillemi, Robert S Hogg, Rolando Barrios, Julio S G Montaner,

<h4>Objective</h4>There is limited research investigating the possible mechanisms of how starting combination antiretroviral therapy (cART) at a higher CD4 cell count decreases mortality. This study investigated the association between initiating cART with short-term and long-term achievement of viral suppression; emergence of any drug resistance and of an AIDS-defining illness (ADI); ... Read more >>

AIDS (AIDS (London, England))
[2015, 29(14):1871-1882]

Cited: 24 times

View full text PDF listing >>





Advertisement

Disclaimer
0.8766 s